CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 23 enrolled
Drug / intervention
oral trimethoprim/sulfamethoxazole +1 moredrug
Likely dose
oral trimethoprim/sulfamethoxazole 80 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00691600
NCT00691600Phase 3Completed
CompareCT.gov

Phase 3 Study Comparing Bactrim to Placebo in the Management of Abscesses < 5cm in the Pediatric Population.

Baylor College of Medicine·interventional·Posted Jun 5, 2008·Updated Jul 1, 2020

In Brief

A Phase 3 clinical trial evaluating oral trimethoprim/sulfamethoxazole and Placebo for Abscess. Completed, enrolled 23 participants across 1 site.

Detailed Summary

The purpose of the study is to compare rates of cure of abscesses with and without antibiotic treatment after incision and drainage. The purpose of this study is to compare successful rates of cure of abscesses less than 5 cm with antibiotic (oral TMP/SMX) versus non-antibiotic treatment after incision and drainage.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbscess
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 5, 2008
Enrollment StartDec 1, 2007
Primary CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 18.1 years ago

Interventions

oral trimethoprim/sulfamethoxazoledrug

80 mg caps or 8 mg/ml suspension every 12 hours for 10 days

Placebodrug

Placebo caps or suspension every 12 hours for 10 days